biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Woohoo! another 9 more cents and I can sell at a 75% loss!

<< Previous

Bullboard Posts

Next >>

Comment by unclepiemanon Jul 30, 2023 10:15pm

107 Views

Post# 35564121

RE:RE:Woohoo! another 9 more cents and I can sell at a 75% loss!

Hey,

Only difference is that if it BK, I can write the whoel thing off at once without having to liquidate to take out capital gains... otherwise I'm forced to sell something good jus tto write this sucker off, unless I'm wanting to carry over the loss which at this point I just want to forget all about it and JD and move on!

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale